|
Sign In to gain access to subscriptions and/or personal tools.
|
Management of Childhood Lead Poisoning
Clinical Impact and Cost-Effectiveness
Deborah E. Glotzer, MD, MPH
Kenneth A. Freedberg, MD, MSc
Howard Bauchner, MD
Objectives. No consensus exists regarding the preferred treatment of childhood lead poi soning. The authors used decision analysis to compare the clinical impacts and cost-ef fectiveness of four management strategies for childhood lead poisoning, and to investigate how effective chelation therapy must be in reducing neuropsychologic sequelae to warrant its use. Methods. The model was based on a 2-year-old child with moderate lead poisoning [blood lead level 1.21 to 1.88 µmol/L (25 to 39 µg/dL)]. The following strategies were compared: 1) no treatment; 2) EDTA provocation testing, followed by chelation if testing is positive (PROV); 3) penicillamine chelation with crossover to EDTA provocation testing if toxicity occurs (PCA); 4) EDTA provocation testing with crossover to penicillamine chelation if testing is negative (EDTA). Results. The EDTA and PCA strategies prevented 22.5% of the cases of reading disability and resulted in an increase of 1.02 quality-adjusted life years compared with no treatment. When the costs of outpatient EDTA testing and chelation are considered, the EDTA strategy is more cost-effective than the PCA strategy; when inpatient costs are considered, the PCA strategy becomes more cost-effective. When costs of remedial education are considered, all strategies are cost-saving compared with no treatment if che lation reduces the risk of lead-induced reading disability by more than 20%. Conclusions. Treatment strategies for childhood lead poisoning vary in clinical impact, cost, and cost- effectiveness. Chelation of the 1.4% of United States preschoolers whose blood lead levels are 1.21 µmol/L (25 µg/dL) or higher could prevent more than 45,000 cases of reading disability, and save more than $900 million per year in overall costs when the costs of remedial education are considered. Key words: lead poisoning; decision analysis; cost anal ysis ; chelation. (Med Decis Making 1995;15:13-24)
Medical Decision Making, Vol. 15, No. 1,
13-23 (1995)
DOI: 10.1177/0272989X9501500104

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. B. Jain, F. Laden, U. Guller, A. Shankar, S. Kazani, and E. Garshick
Relation between Blood Lead Levels and Childhood Anemia in India
Am. J. Epidemiol.,
May 15, 2005;
161(10):
968 - 973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Griebsch, J. Coast, and J. Brown
Quality-Adjusted Life-Years Lack Quality in Pediatric Care: A Critical Review of Published Cost-Utility Studies in Child Health
Pediatrics,
May 1, 2005;
115(5):
e600 - e614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Brown
Costs and Benefits of Enforcing Housing Policies to Prevent Childhood Lead Poisoning
Med Decis Making,
December 1, 2002;
22(6):
482 - 492.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Kemper, W. C. Bordley, and S. M. Downs
Cost-effectiveness Analysis of Lead Poisoning Screening Strategies Following the 1997 Guidelines of the Centers for Disease Control and Prevention
Arch Pediatr Adolesc Med,
December 1, 1998;
152(12):
1202 - 1208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Casey, C. Wiley, R. Rutstein, and J. Pinto-Martin
Longitudinal Assessment for Lead Poisoning
Clinical Pediatrics,
February 1, 1996;
35(2):
58 - 61.
[Abstract]
[PDF]
|
 |
|
|
|